Eyes absent (EYA) proteins are defined by a conserved C-terminal EYA domain (ED) that both contributes to its function as a transcriptional coactivator by mediating protein-protein interactions and possesses intrinsic protein tyrosine phosphatase activity. Mutations in human EYA1 result in an autosomal dominant disorder called branchio-oto-renal (BOR) syndrome as well as congenital cataracts and ocular defects (OD). Both BOR-and OD-associated missense mutations alter residues in the conserved ED as do three missense mutations identified from Drosophila eya alleles. To investigate the molecular mechanisms whereby these mutations disrupt EYA function, we tested their activity in a series of assays that measured in vivo function, phosphatase activity, transcriptional capability, and protein-protein interactions. We find that the OD-associated mutations retain significant in vivo activity whereas those derived from BOR patients show a striking decrease or loss of in vivo functionality. Protein-protein interactions, either with its partner transcription factor Sine oculis or with EYA itself, were not significantly compromised. Finally, the results of the biochemical assays suggest that both loss of protein tyrosine phosphatase activity and reduced transcriptional capability contribute to the impaired EYA function associated with BOR/OD syndrome, thus shedding new light into the molecular mechanisms underlying this disease.
R ETINAL specification and development in both vera network, contribute to a diverse array of essential developmental processes in Drosophila and in vertetebrates and invertebrates rely on the concerted brates. Consequently, null mutations are lethal and exactions of a group of evolutionarily conserved transcriphibit complex defects in a variety of tissues and organs tion factors and cofactors that include twin of eyeless (toy), (reviewed in Wawersik and Maas 2000; Silver and eyeless (ey), eyes absent (eya), sine oculis (so), and dachshund . (dac), with the human homologs referred to as PAX6 EYA family members encode novel nuclear proteins (homolog of both toy and ey), EYA, SIX, and DACH, defined by a conserved ‫-572ف‬amino-acid C-terminal morespectively (reviewed in Wawersik and Maas 2000;  tif, referred to as the EYA domain (ED), which mediates Pappu and Mardon 2002). PAX6 lies atop the hierarchy direct interactions with SO/SIX and DAC/DACH (Bonand directly activates expression of EYA and SIX family ini et al. 1993; Chen et al. 1997; Pignoni et al. 1997 ; members, which operate synergistically to induce exZimmerman et al. 1997; Heanue et al. 1999; Ohto et al. pression of DACH and other downstream genes (re-1999) . The N terminus of EYA contributes a conserved viewed in Pappu and Mardon 2002) . Because of their trans-activation function to an EYA-SO bipartite tranprominent role in eye development, exemplified in Droscription factor in which the homeodomain protein sophila by the "eyeless" phenotype and visual system SO/SIX provides the DNA-binding moiety (Ohto et al. defects associated with loss-of-function mutations and 1999; Silver et al. 2003) . The mechanistic implications the ability to induce formation of ectopic eye tissue of EYA-DACH interactions are less clear. DAC/DACH upon overexpression, these genes have been referred proteins function as both coactivators and corepressors to collectively as the retinal determination (RD) gene and may also have DNA-binding capability, implying network (Pappu and Mardon 2002) . In addition to their roles in tethering EYA to the DNA and influencing tranroles in the eye, all RD genes, either individually or as scription of downstream genes Kim et al. 2002; Li et al. 2003) . Recent work revealed that the ED of EYA also exhibits catalytic activity, functioning tween corepressor and coactivator states, suggesting an sizes the importance of establishing in vivo model systems that can provide the critical foundation on which integral contribution to regulating transcriptional output (Li et al. 2003) .
to base subsequent in vitro studies. While such analyses are at best cumbersome in mouse, Drosophila, and in The four mammalian EYA paralogs, designated EYA1-4, exhibit distinct but overlapping expression patterns, particular the fly eye where the function and regulation of eya have been extensively studied, provides an ideal with EYA1-3 expressed in the developing eye in a PAX6-dependent manner (Xu et al. 1997; in vivo system in which to explore the question of how these missense mutations associated with human disease 1997; Borsani et al. 1999; Hanson 2001) . Emphasizing the high degree of functional conservation among EYA might alter EYA function. The ability of mammalian EYA genes to complement Drosophila eya further valiproteins, mammalian EYA1, EYA2, or EYA3 transgenes can rescue the eyeless phenotype of Drosophila eya mudates this approach. tations with comparable efficiency (Bonini et al. 1997;  Furthermore, given the recent discovery that EYA, in Bui et al. 2000) ; EYA4 has not yet been tested in such addition to operating as a transcriptional coactivator in assays. In terms of practical utility, this high degree of conjunction with SIX proteins (Ohto et al. 1999 to explore the possibility that some of the missense Human EYA1 was positionally cloned as the gene remutations in the conserved ED might disrupt this new sponsible for branchio-oto-renal (BOR) syndrome, an function. Thus, in addition to determining their activity autosomal dominant disorder characterized by the assoin our Drosophila eye in vivo assays, we have also examciation of branchial arch anomalies, otic defects, and a ined the five missense mutations in EYA1 derived from broad spectrum of renal abnormalities (Abdelhak et human patients with BOR syndrome and/or ocular deal. 1997b; Vincent et al. 1997) . The clinical features of fects, with the three missense mutations identified in BOR syndrome manifest early during development with Drosophila eya loss-of-function alleles, for defects in variable penetrance, with hearing loss being the most phosphatase and/or transcriptional activities. Our work commonly associated defect (Rodriguez Soriano 2003) ;
provides the first analysis of human patient-derived EYA for a description of the clinical features of BOR synmutations in an in vivo developmental context and sugdrome as well as a list of the associated molecular lesions gests that defects in both phosphatase and transcription in EYA1, see http://www.medicine.uiowa.edu/pendred functions likely contribute to the molecular causes of andbor/BOR.htm. Mouse knockouts of Eya1 have a sim-BOR syndrome in humans and to compromised develilarly complex phenotype characterized by craniofacial, opment in flies. ear, and kidney defects (Xu et al. 1999) .
The fact that BOR patients and murine EYA1 knockout mice generally lack ocular defects has led to the MATERIALS AND METHODS suggestion that in contrast to the fly, where eya plays a the EYA-SIX transcription factor (Buller et al. 2001; Ozaki et al. 2002) . However, not all missense mutations T250M, 5Ј tgggacttggacgaaatgatcatcatctttcatt 3Ј; E281K, 5Ј caggtttaaccatgaaagaaatgatttttg 3Ј; that were examined in these studies impaired function G344S, 5Ј tcatctgtgggcgttcagtcaggtgtggactgga 3Ј; of the EYA-SIX transcription factor, nor were results T393I, 5Ј agagatcgaggtgctgattgactcctggttaggaa 3Ј; entirely consistent among the various in vitro assays used L405P, 5Ј cgctcaagtccttgcctctcatccagtctc 3Ј; in the analyses (Buller et al. 2001; Ozaki et al. 2002) . L423R, 5Ј ctgatcactaccacgcagcgggttccagccctggc 3Ј; This variability raises the possibility that the molecular K465G, 5Ј attgtttcgaggtttgggggaaaagtcacatatgt 3Ј; G473E, 5Ј catatgtagtgattgaagatggacgagatg 3Ј.
basis of BOR disease may be quite complex and empha- T497M  T332  T250  E363K  E528  E281  R547G  R715  K465  T643I  T475  T393  G723E  G555  G473 protease inhibitor cocktail tablet (Roche, Indianapolis) per 10 ml], immunoprecipitation with anti-Flag conjugated beads The mutations in mouse Eya3 were introduced into the GST-ED fusion protein (aa 237-510 of mouse EYA3) described (Sigma, St. Louis), and Western blotting were done as previously described in Silver et al. (2003) . Guinea pig (GP) in Tootle et al. (2003b) . For Drosophila eya, site-directed mutagenesis was performed on a Kpn I/Sal I fragment of Droanti-EYA (1:10,000), GP anti-SO (1:10,000), and mouse anti-MYC (1:10) were used for Western blotting. Anti-SO antibody sophila eya in Bluescript (Stratagene, La Jolla, CA). A threepiece ligation linked the flag-epitope-tagged N terminus of was raised by injecting guinea pigs with full-length recombinant GST-SO fusion protein. EYA, obtained as an EcoRI/Kpn I fragment from pRmHa3-flageya (Silver et al. 2003) , with the mutagenized Kpn I/Sal I EYA C terminus into the EcoRI/Sal I sites of pRmHa3 to generate the metallothionein promoter-driven expression constructs RESULTS AND DISCUSSION used in the transcription and co-immunoprecipitation studies.
Missense mutations associated with BOR syndrome
The mutant constructs were shuttled into the P-element transformation vector pUAST as an EcoRI/Sal I fragment. Establishand ocular defects compromise EYA function in vivo: The Drosophila versions were used for in vivo and cell in BSSK-TATA-luciferase (Silver et al. 2003) . Transcription culture experiments while the murine constructs were assays were performed in triplicates as previously described used for in vitro biochemical studies. Difficulty with ob- (Silver et al. 2003) , using 5 g per assay of the reporter gene and each expression plasmid (expression plasmids previously taining sufficient amounts of recombinant protein has described in Silver et al. 2003; Tootle et al. 2003b) , and precluded us, and others previously (Li et al. 2003) , from normalized using 1 g of Actin-lacZ per assay. using mammalian EYA1 in the biochemical analyses.
Co-immunoprecipitation and Western blots: Transfection
However, the ability of both mammalian EYA1 and EYA3 and cell lysis [lysis buffer: 300 mm NaCl, 50 mm Tris (pH 7.5), to complement Drosophila eya mutations with compara-2 mm EDTA, 2 mm EGTA, 1% NP-40, and one complete mini ble efficiency (Bonini et al. 1997; Bui et al. 2000) argues Figure 1 .-Human and Drosophiladerived missense mutations in the conserved EYA domain. Amino acid sequence alignment of EYA domains (ED) from human (hEYA1), mouse (mEya3), and Drosophila (dEYA) showing the substitution mutations analyzed. Identical amino acid residues that have been mutated are boxed, immediately above each boxed area is the site-directed mutation used in this study, and in superscript is the source of mutation. Residues that are shaded represent the haloacid dehalogenase (HAD) motifs and the putative Sine oculis binding sites are underlined with a solid line. mEya3 protein was used for phosphatase assays and dEYA was used for all other experiments. It should be noted that the S487P BOR mutation affects a residue that is not strictly conserved among EYA proteins. Blast searches reveal multiple variants at this position including the L in mouse EYA3, as well as T, A, and N in various other vertebrate EYA homologs (data not shown). Such variation, when considered in light of the equivalent ability demonstrated by different mammalian EYA paralogs to functionally complement Drosophila eya mutations, suggests that it is the consequences of introducing a P (proline) in this particular position of the protein, rather than the exact identity of the naturally occurring residue, that are important. strongly that these are functionally analogous proteins
The second set of in vivo experiments used a genetic rescue assay to assess the function of these eight mutant and validates the approach we have taken. For clarity, and to emphasize the origin of the eight mutations transgenes in the context of normal, rather than ectopic, eye development. Specifically we tested their abilexamined in this study, we have added the superscripts "FLY," "BOR," "OD," and "BORϩOD" to the mutation ity to complement the eye-specific null allele eya 2 that completely lacks eye tissue. Consistent with the results of name.
We first investigated the ability of mutant EYA transthe ectopic eye induction experiment, transgenic lines carrying mutations with the three OD-derived amino genes to function in vivo using the genetically tractable Drosophila system. It has previously been shown that acid substitutions R715G OD , E528K
OD , and G594S
BORϩOD showed significant rescue of eye tissue. In fact, the perectopic expression of EYA can induce formation of eye tissue outside of the normal visual field (Bonini et al. centage of flies showing rescue, defined by the presence of eye tissue within the normal visual field, was almost 1997; Chen et al. 1997; Pignoni et al. 1997) and that quantification of the efficiency with which a particular comparable to that obtained by expressing wild-type EYA transgenes (Figure 2 , B, C, and G-I). However, the transgene induces ectopic eyes can reveal relative activity differences between various EYA mutations (Hsiao extent of rescue, judged by comparing the overall size of the recovered eye tissue, reveals that these three mutaet al. Silver et al. 2003; Tootle et al. 2003b) . To control for transgene-specific position effects, multiple tions have significantly reduced activity, consistent with their association with a pathological condition in human independent insertion lines were tested for each mutation and expression of the mutant EYA proteins at levels patients ( Figure 2) . Interestingly, the rescue obtained by expressing G59-comparable to that obtained with wild type was confirmed by immunoblot analysis (data not shown). 4S BORϩOD transgenes was phenotypically distinct from that of all other EYA transgenes, whether wild type or Interestingly, of the eight EYA mutations tested, only the three OD-derived mutations, R715G
mutant, we have ever tested (Tootle et al. 2003b) . Specifically the recovered eye tissue was more dorsally loand G594S BORϩOD , retained the ability to induce ectopic eyes (Figure 2A ). Of these, E528K
OD exhibited activity cated than usual and was almost always split into multiple independent fields ( Figure 2I ). Perhaps this distinct comparable to that of wild-type EYA transgenes, whereas R715G OD and G594S BORϩOD showed a two-and fivefold in vivo behavior reflects a gain-of-function or neomorphic aspect to this allele that underlies the compound respective reduction in activity. (A) The percentage of ectopic eye induction value associated with expression of the different mutations was derived from analysis of multiple independent transgenic lines. The y -axis refers to the penetrance of ectopic eyes and does not account for differences in size of the ectopic eye patch. However, it is important to note that the qualitative nature of the ectopic eye patches correlates tightly with overall penetrance, and hence activity level, of each transgene. (B) The percentage of flies carrying the genotype UAS-eya/dpp-GAL4 that showed rescue of the eya 2 eyeless phenotype. Again, the scoring was not weighted to account for differences in size of the patch of rescued eye tissue. (C-J) Scanning electron micrographs of adult eyes showing the rescue of eya 2 eyeless phenotype by different transgenes. Genotypes are indicated. genes ( Figure 2 , F and J), while the others lacked activity be informative to sequence the SIX1 coding region to see if a mutation in SIX1 might be responsible for the in this assay. Emphasizing again that these differences reflect activity changes rather than reduced protein lev-BOR symptoms, as such mutations have recently been linked to BOR syndrome (Ruf et al. 2004) . Future identiels, comparable protein expression levels and nuclear localization were observed for both mutant and wildfication and functional analysis of additional missense mutations in human SIX1 and EYA1 will provide importype EYA transgenes (data not shown).
Together, the results of these two in vivo experiments tant tools with which to explore further the molecular determinants of these disorders. suggest an allelic series in which T643I BORϩOD retain significant activity. rived from null Drosophila eya alleles and from human patients suffering from BOR syndrome and/or OD all Thus, as assayed in the context of in vivo eye development assays in Drosophila, the mutations associated with map to the portion of the conserved ED (Figure 1 ) that has recently been shown to possess intrinsic protein OD in humans retained high although still lower than normal activity levels, whereas those originating from phosphatase activity (Li et al. 2003; Rayapureddi et al. 2003; Tootle et al. 2003b ). Therefore to further our patients manifesting BOR-specific defects lacked significant function. The loss of activity of the Drosophilaunderstanding of the physiological relevance of EYA's phosphatase activity, we asked whether any of these nonderived mutations is consistent with their having been isolated as loss-of-function alleles (Bui et al. 2000 ; Rebay sense mutations impaired catalytic function. Specifically, we tested the ability of bacterially exet al. 2000) .
On the basis of these analyses, it is possible that the pressed and purified GST-ED fusion proteins to dephosphorylate the tyrosyl-phosphorylated peptide I(pY)GEF, molecular mechanisms linking mutations in EYA1 to either BOR or OD are distinct. In the case of the human which we had previously identified as a good substrate ( latter case activity was not sufficiently robust to permit kinetic analyses (Table 5 ). These same two mutations exPhosphatase activity of mutant GST-mEYA3 fusion proteins hibited robust in vivo activity (Figure 2) two of their usual binding partners is retained ( Figure  4 ) makes it unlikely that the mutant EYA proteins are appeared normal in only one of the mutations tested, simply misfolded. Therefore these results suggest that T250M FLY , a somewhat unexpected result because this loss of phosphatase activity contributes to the BOR phemutation affects a conserved residue within motif I of notype and perhaps to the OD phenotype as well. the catalytic domain (Figure 1 ). The fact that this mutaImpaired trans-activation potential of mutant EYA tion lacks activity in the in vivo assays (Figure 2) suggests proteins: To explore the effects of these mutations on that an essential function other than phosphatase activ-EYA's second function as a transcriptional cofactor, we ity has been compromised, such as perhaps interaction have tested their trans-activation ability in two Drosophwith a critical binding partner.
ila cell-based transcription assays. The first uses a multiTwo additional mutations, G344S
BORϩOD and K465G OD , merized regulatory element from the mammalian Na ϩ / K ϩ -ATPase ␣1-subunit fused upstream of the luciferase retained measurable phosphatase activity, although in the gene (ARE-luciferase) that we have previously shown to be of trans-activation potential, showing two-and fivefold reductions in activity in the ARE and LMEE assays, reresponsive to the EYA-SO bipartite transcription factor ( Figure 3A ; Silver et al. 2003) . The second reporter places spectively. More severely compromised were T643I FLY , G723E FLY , and L673R BOR , which exhibited 10-and 5-fold luciferase downstream of a single copy of a 252-bp minimal enhancer element from the second intron of the Drosophreductions in activity in the ARE and LMEE assays, respectively. Finally, transcriptional output observed with ila lozenge (lz) gene (LMEE-luciferase) that has recently been shown to be responsive to SO activity in the fly eye (Yan E528K OD and G594S BORϩOD was not significantly above the reporter-alone baseline, indicating a complete loss et al. 2003) . In Drosophila S2 cells, LMEE-luciferase is activated to low levels when expressed alone or with either of trans-activation potential. Together these results suggest that impaired ability to activate transcription in EYA or SO alone, but when coexpressed with both EYA and SO, significant activation is observed ( Figure 3B and conjunction with SO/SIX appears to be a major consequence of mutations associated with BOR/OD syndata not shown). This activation is due to direct binding of SO to the LMEE sequence, as mutation of the SO- component of the EYA-SO transcription factor. Indeed, previous in vitro analyses using yeast two-hybrid and GST Using these two independent assays, one relying on an artificial multimerized element ( Figure 3A ) and the pull-down assays suggested that this might be the case (Bui et al. 2000; Buller et al. 2001; Ozaki et al. 2002) . other using a native element from an endogenous Drosophila target gene ( Figure 3B ), we tested whether the However, the artificial context of the assay systems, combined with the fact that full-length proteins were not BOR, OD, and Drosophila-derived EYA mutants retain the ability to trans-activate in concert with SO. Although tested, raised the possibility that the reduced binding capacity might not accurately reflect the situation in the absolute levels of activation differed between the two reporters, similar trends were observed, with all vivo. To investigate this possibility, co-immunoprecipitation studies were performed from Drosophila cells comutants showing some reduction in activity relative to wild-type EYA. Immunohistochemical and immunoblottransfected with full-length epitope-tagged expression constructs. All mutant EYA proteins complexed effiting analyses revealed that the mutant proteins all localize appropriately to the nucleus (data not shown) and ciently with SO although S655P BOR -SO interactions were reduced by almost threefold relative to wild-type EYAthat expression levels between wild-type and mutant EYA proteins appear comparable ( Figure 3C ). This confirms SO and G723E FLY also showed a slight reduction in binding to SO ( Figure 4A ). Thus, our co-immunoprecipitathat the reduced transcriptional output reflects loss of trans-activation potential rather than abnormal subcellution studies argue strongly that the various EYA mutants do not significantly compromise interactions with SO lar localization or instability of the mutant proteins.
While all mutants exhibited reduced trans-activation, when placed in the more physiologically relevant context of a Drosophila cell and that therefore reduced the degree of impairment varied. R715G
OD retained robust trans-activation potential, exhibiting only a twofold binding efficiency is unlikely to be a primary contributor to their impaired trans-activation ability. activity reduction relative to wild-type EYA in both assays. S655P
BOR and T497M FLY also exhibited only mild loss With respect to the extent of impairment of transcrip- EYA with an efficiency comparable to that of wild-type EYA-EYA interactions ( Figure 4B ). The apparently nor- parisons of EYA-containing complexes found in normal vs. BOR/OD model tissues should shed new light on the molecular basis of BOR/OD diseases in humans. tional output, our results agree well with previous stud-
In conclusion, our work provides the first functional ies, although several differences raise the interesting analysis of human patient-derived EYA mutations in an possibility that the effects of these mutations on tranin vivo developmental context and suggests that defects scriptional output may differ from target gene to target in both phosphatase and transcription functions likely gene. For example, in our two assays, the E528K OD mutacontribute to the molecular causes of BOR syndrome tion is inactive whereas in myogenin promoter-based tranin humans and to compromised development in flies scriptional assay activity it was equivalent to wild type (Table 6 ). Intriguingly, OD patient-derived mutations (Ozaki et al. 2002) . Conversely, in our systems S655P BOR retain significant in vivo functionality relative to that of retained significant, albeit reduced, transcriptional ac-BOR patient-derived mutations, suggesting that distinct tivity whereas activity was not detected in the myogenin molecular determinants may underly the different phepromoter-based assay (Ozaki et al. 2002) . Given the extennotypic manifestations of these two classes of human sive conservation that has been demonstrated among EYA EYA mutations. Continued exploitation of the powerful homologs, the most plausible explanation is that such Drosophila in vivo model systems we have established differences reflect the physiological complexity of transhould provide additional insight into how EYA's two scriptional output mediated by EYA. Specifically, the functions as transcription factor and phosphatase are mutant EYA proteins might recruit different sets of incoordinated and coregulated during normal developteracting proteins to the target promoters, leading to ment and by extension how misregulation of one or abnormal transcriptional output. If correct, then to fully both functions contributes to human disease. understand the molecular basis of BOR syndrome and Utpal Banerjee generously provided the LMEE reagents prior to optical defects in humans, a better understanding of publication. We thank members of the Rebay lab for helpful discusthe full spectrum of target genes regulated by the EYAsions throughout the course of this work. S.J.S. was supported by a Howard Hughes Medical Institute predoctoral fellowship, T.L.T. was SIX transcription factor and how the transcriptional supported by a Ludwig Foundation predoctoral fellowship, and this profile is altered in the various EYA mutant backgrounds work was supported in part by National Institutes of Health grant R01 will be required. Furthermore, our finding that phos-EY 12549-06 to I.R.
phatase activity is impaired in many of the associated mutations suggests that the contribution of EYA's phosphatase activity to transcriptional output at different LITERATURE CITED target genes may also be critical. all EYA mutants co-immunoprecipitate with wild-type
